{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T22:12:23Z","timestamp":1773871943163,"version":"3.50.1"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jad.2024.10.104","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T18:30:28Z","timestamp":1729621828000},"page":"1021-1030","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Hypomanic symptoms in major depressive disorder: Prognostic impact and treatment issues"],"prefix":"10.1016","volume":"369","author":[{"given":"Paolo","family":"Olgiati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siegfried","family":"Kasper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Zohar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Souery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Ferentinos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Rujescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Zanardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gernot","family":"Fugger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariangela","family":"Tripodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard T.","family":"Baune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Fabbri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Mendlewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Serretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2024.10.104_bb0005","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0165-0327(02)00330-0","article-title":"Family history validation of the bipolar nature of depressive mixed states","volume":"73","author":"Akiskal","year":"2003","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.10.104_bb0010","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jad.2004.12.004","article-title":"Agitated \u201cunipolar\u201d depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy","volume":"85","author":"Akiskal","year":"2005","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.10.104_bb0015","article-title":"Diagnostic and statistical manual of mental disorders (DSM-5\u00ae)","author":"American Psychiatric Association","year":"2013","journal-title":"American Psychiatric Pub."},{"key":"10.1016\/j.jad.2024.10.104_bb0020","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/archgenpsychiatry.2011.87","article-title":"Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE study","volume":"68","author":"Angst, J., Azorin, J.-M., Bowden, C.L., Perugi, G., Vieta, E., Gamma, A., Young, A.H., BRIDGE Study Group","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2024.10.104_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.comppsych.2021.152264","article-title":"Differences in antipsychotic treatment between depressive patients with and without a suicide attempt","volume":"109","author":"Asp","year":"2021","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.jad.2024.10.104_bb0030","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/15622975.2019.1635270","article-title":"Results of the European Group for the Study of resistant depression (GSRD) - basis for further research and clinical practice","volume":"20","author":"Bartova","year":"2019","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2024.10.104_bb0035","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.pnpbp.2004.11.010","article-title":"Mixed depression: a clinical marker of bipolar-II disorder","volume":"29","author":"Benazzi","year":"2005","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2024.10.104_bb0040","doi-asserted-by":"crossref","unstructured":"Benazzi, F., 2007. Bipolar disorder--focus on bipolar II disorder and mixed depression. Lancet 369, 935\u2013945. doi:https:\/\/doi.org\/10.1016\/S0140-6736(07)60453-X.","DOI":"10.1016\/S0140-6736(07)60453-X"},{"key":"10.1016\/j.jad.2024.10.104_bb0045","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.eurpsy.2007.07.003","article-title":"Reviewing the diagnostic validity and utility of mixed depression (depressive mixed states)","volume":"23","author":"Benazzi","year":"2008","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jad.2024.10.104_bb0050","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.pnpbp.2008.10.007","article-title":"Classifying mood disorders by age-at-onset instead of polarity","volume":"33","author":"Benazzi","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2024.10.104_bb0055","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jad.2020.08.067","article-title":"Validity of retrospectively-reported depressive episodes","volume":"277","author":"Birk","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.10.104_bb0060","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1176\/appi.ajp.162.7.1351","article-title":"A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression","volume":"162","author":"Calabrese","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.10.104_bb0065","article-title":"Predictive factors and treatment of postpartum mania: a representative case","author":"Constantino","year":"2023","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.10.104_bb0070","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jad.2010.06.036","article-title":"Is unrecognized bipolar disorder a frequent contributor to apparent treatment resistant depression?","volume":"127","author":"Correa","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.10.104_bb0075","doi-asserted-by":"crossref","first-page":"e994","DOI":"10.4088\/JCP.16m11190","article-title":"Determining if borderline personality disorder and bipolar disorder are alternative expressions of the same disorder: results from the National Epidemiologic Survey on alcohol and related conditions","volume":"78","author":"de la Rosa","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2024.10.104_bb0080","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/ijnp\/pyy009","article-title":"Major depression and the degree of suicidality: results of the European Group for the Study of resistant depression (GSRD)","volume":"21","author":"Dold","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2024.10.104_bb0085","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/j.euroneuro.2016.10.005","article-title":"Pharmacological treatment strategies in unipolar depression in European tertiary psychiatric treatment centers - a pharmacoepidemiological cross-sectional multicenter study","volume":"26","author":"Dold","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2024.10.104_bb0090","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/YIC.0000000000000421","article-title":"Risk of conversion to bipolar disorder in patients with late-onset major depression","volume":"37","author":"Elefante","year":"2022","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.10.104_bb0095","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1037\/bul0000367","article-title":"A meta-analytic review of the relationship between explicit memory bias and depression: depression features an explicit memory bias that persists beyond a depressive episode","volume":"148","author":"Everaert","year":"2022","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.jad.2024.10.104_bb0100","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/bdi.12537","article-title":"On the centrality of mixed features in mood disorders: listening to Kraepelin and Weygandt and moving forward","volume":"19","author":"Fagiolini","year":"2017","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2024.10.104_bb0105","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/YIC.0000000000000454","article-title":"Does celecoxib with sodium valproate have an augmentation effect on acute mania in bipolar disorder? A double-blind controlled clinical trial in Iran","volume":"38","author":"Faridhosseini","year":"2023","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.10.104_bb0110","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1176\/appi.ajp.2010.10030328","article-title":"Subthreshold hypomanic symptoms in progression from unipolar major depression to bipolar disorder","volume":"168","author":"Fiedorowicz","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.10.104_bb0115","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1017\/S1092852920002047","article-title":"Bipolar spectrum disorder masquerading as treatment resistant unipolar depression","volume":"27","author":"Fogelson","year":"2022","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2024.10.104_bb0120","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2174\/1745017901410010042","article-title":"Misdiagnosed hypomanic symptoms in patients with treatment-resistant major depressive disorder in Italy: results from the improve study","volume":"10","author":"Francesca","year":"2014","journal-title":"Clin. Pract. Epidemiol. Ment. Health"},{"key":"10.1016\/j.jad.2024.10.104_bb0125","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.cpr.2014.06.001","article-title":"A meta-analytic review of mood-congruent implicit memory in depressed mood","volume":"34","author":"Gaddy","year":"2014","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.jad.2024.10.104_bb0130","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1017\/S1092852917000025","article-title":"Remission and recovery associated with lurasidone in the treatment of major depressive disorder with subthreshold hypomanic symptoms (mixed features): post-hoc analysis of a randomized, placebo-controlled study with longer-term extension","volume":"22","author":"Goldberg","year":"2017","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2024.10.104_bb0135","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1007\/s12325-022-02112-6","article-title":"Treatment patterns among patients with bipolar disorder in the United States: a retrospective claims database analysis","volume":"39","author":"Jain","year":"2022","journal-title":"Adv. Ther."},{"key":"10.1016\/j.jad.2024.10.104_bb0140","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1176\/appi.ajp.2016.16020176","article-title":"Early improvement in work productivity predicts future clinical course in depressed outpatients: findings from the CO-MED trial","volume":"173","author":"Jha","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.10.104_bb0145","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jad.2022.01.082","article-title":"Diagnostic conversion from unipolar to bipolar affective disorder-a population-based study","volume":"301","author":"Jo","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.10.104_bb0150","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4088\/JCP.15m10381","article-title":"A new prediction model for evaluating treatment-resistant depression","volume":"78","author":"Kautzky","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2024.10.104_bb0155","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/acps.12959","article-title":"Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study","volume":"139","author":"Kautzky","year":"2019","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2024.10.104_bb0160","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1177\/0706743716659417","article-title":"Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the Management of Adults with major depressive disorder: section 3","volume":"61","author":"Kennedy","year":"2016","journal-title":"Pharmacological Treatments. Can. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.10.104_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2021.114275","article-title":"A piece of the puzzle: does bipolarity partly explain the high prevalence of treatment resistance in depression?","volume":"307","author":"Kikkert-Hurkens","year":"2022","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2024.10.104_bb0170","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0924-9338(15)30355-2","article-title":"More Liberal \u201cwith mixed features\u201d threshold for bipolar depression may be not only more inclusive, but also more clinically relevant","volume":"30","author":"Kim","year":"2015","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jad.2024.10.104_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2021.114194","article-title":"Response and remission rates during 24 weeks of mood-stabilizing treatment for bipolar depression depending on early non-response","volume":"305","author":"K\u00f6hler-Forsberg","year":"2021","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2024.10.104_bb0180","series-title":"Disruptive Psychopharmacology","first-page":"141","article-title":"Ketamine for depression: Advances in clinical treatment, rapid antidepressant mechanisms of action, and a contrast with serotonergic psychedelics","author":"Kojic","year":"2022"},{"key":"10.1016\/j.jad.2024.10.104_bb0185","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/acps.12140","article-title":"DSM-5 criteria for depression with mixed features: a farewell to mixed depression","volume":"129","author":"Koukopoulos","year":"2014","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2024.10.104_bb0190","doi-asserted-by":"crossref","first-page":"712","DOI":"10.4088\/JCP.v67n0504","article-title":"Agitated \u201cunipolar\u201d major depression: prevalence, phenomenology, and outcome","volume":"67","author":"Maj","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2024.10.104_bb0195","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jad.2024.06.099","article-title":"Cariprazine in the acute treatment of unipolar and bipolar depression: a systematic review and meta-analysis","volume":"362","author":"Martins-Correia","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.10.104_bb0200","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jad.2017.12.062","article-title":"Is recurrence in major depressive disorder related to bipolarity and mixed features? Results from the BRIDGE-II-mix study","volume":"229","author":"Mazzarini, L., Kotzalidis, G.D., Piacentino, D., Rizzato, S., Angst, J., Azorin, J.-M., Bowden, C.L., Mosolov, S., Young, A.H., Vieta, E., Girardi, P., Perugi, G., BRIDGE-II-Mix Study Group","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.10.104_bb0205","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/wps.21120","article-title":"Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions","volume":"22","author":"McIntyre","year":"2023","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jad.2024.10.104_bb0210","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jad.2016.12.033","article-title":"Major depressive disorder with subthreshold hypomanic (mixed) features: a real-world assessment of treatment patterns and economic burden","volume":"210","author":"McIntyre","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.10.104_bb0215","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jad.2014.09.026","article-title":"The prevalence and illness characteristics of DSM-5-defined \u201cmixed feature specifier\u201d in adults with major depressive disorder and bipolar disorder: results from the international mood disorders collaborative project","volume":"172","author":"McIntyre","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.10.104_bb0220","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1017\/S1092852919001287","article-title":"Cariprazine efficacy in bipolar I depression with and without concurrent manic symptoms: post hoc analysis of 3 randomized, placebo-controlled studies","volume":"25","author":"McIntyre","year":"2020","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2024.10.104_bb0225","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/YIC.0000000000000505","article-title":"Manic episode in a patient with pancreatic adenocarcinoma: a case report","volume":"39","author":"Mena","year":"2024","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.10.104_bb0230","article-title":"OpenStat","volume":"version 1","author":"Miller","year":"2007","journal-title":"Free Software package"},{"key":"10.1016\/j.jad.2024.10.104_bb0235","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jad.2022.11.039","article-title":"Comparison of bipolar disorder type II and major depressive disorder","volume":"323","author":"Miola","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.10.104_bb0240","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.10.104_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci12010092","article-title":"Mixed depression: a Mini-review to guide clinical practice and future research developments","volume":"12","author":"Natale","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.jad.2024.10.104_bb0250","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1399-5618.2011.00957.x","article-title":"Subthreshold bipolarity: diagnostic issues and challenges","volume":"13","author":"Nusslock","year":"2011","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2024.10.104_bb0255","first-page":"500","article-title":"Depression preceding diagnosis of bipolar disorder","volume":"11","author":"O\u2019Donovan","year":"2020","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jad.2024.10.104_bb0260","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/YIC.0000000000000416","article-title":"Persistence of suicidal ideation within acute phase treatment of major depressive disorder: analysis of clinical predictors","volume":"37","author":"Olgiati","year":"2022","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.10.104_bb0265","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/YIC.0000000000000468","article-title":"In search of clinical targets for suicide prevention in major depressive disorder","volume":"38","author":"Olgiati","year":"2023","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.10.104_bb0270","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/YIC.0000000000000479","article-title":"Antidepressant emergent mood switch in major depressive disorder: onset, clinical correlates and impact on suicidality","volume":"38","author":"Olgiati","year":"2023","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.10.104_bb0275","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/da.20191","article-title":"Retrospective analysis of psychomotor agitation, hypomanic symptoms, and suicidal ideation in unipolar depression","volume":"23","author":"Olgiati","year":"2006","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jad.2024.10.104_bb0280","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.psychres.2014.07.040","article-title":"The hypomanic personality scale: a measure of personality and\/or bipolar symptoms?","volume":"220","author":"Parker","year":"2014","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2024.10.104_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034757","article-title":"A 6 week randomized double-blind placebo-controlled trial of ziprasidone for the acute depressive mixed state","volume":"7","author":"Patkar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jad.2024.10.104_bb0290","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1600-0447.2008.01298.x","article-title":"Irritability is associated with anxiety and greater severity, but not bipolar spectrum features, in major depressive disorder","volume":"119","author":"Perlis","year":"2009","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2024.10.104_bb0295","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/bdi.12538","article-title":"Mixed state and suicide: is the effect of mixed state on suicidal behavior more than the sum of its parts?","volume":"20","author":"Persons","year":"2018","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2024.10.104_bb0300","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.3390\/ijms17101700","article-title":"Do atypical antipsychotics have antisuicidal effects? A hypothesis-generating overview","volume":"17","author":"Pompili","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jad.2024.10.104_bb0305","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17m11970","article-title":"Antipsychotic prescriptions among adults with major depressive disorder in office-based outpatient settings: national trends from 2006 to 2015","volume":"79","author":"Rhee","year":"2018","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2024.10.104_bb0310","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/JCP.0b013e318299d2d5","article-title":"Antidepressant response and subthreshold bipolarity in \u201cunipolar\u201d major depressive disorder: implications for practice and drug research","volume":"33","author":"Rihmer","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.10.104_bb0315","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jad.2023.01.045","article-title":"Predicting bipolar disorder I\/II in individuals at clinical high-risk: results from a systematic review","volume":"325","author":"Salazar de Pablo","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.10.104_bb0320","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000358808","article-title":"Mixed depression: clinical features and predictors of its onset associated with antidepressant use","volume":"83","author":"Sani","year":"2014","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.jad.2024.10.104_bb0325","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0165-0327(03)00159-9","article-title":"Evaluating the inter-episode stability of depressive mixed states","volume":"81","author":"Sato","year":"2004","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.10.104_bb0330","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/YIC.0000000000000488","article-title":"Clinical specificity profile for novel rapid acting antidepressant drugs","volume":"38","author":"Scala","year":"2023","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.10.104_bb0335","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1159\/000514127","article-title":"Irritable mood and subthreshold hypomanic episodes correlate with more severe major depression","volume":"80","author":"Serretti","year":"2021","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.jad.2024.10.104_bb0340","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/s41380-021-01381-x","article-title":"A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials","volume":"27","author":"Sforzini","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2024.10.104_bb0345","doi-asserted-by":"crossref","first-page":"376","DOI":"10.9758\/cpn.2018.16.4.376","article-title":"Pharmacological treatment of major depressive episodes with mixed features: a systematic review","volume":"16","author":"Shim","year":"2018","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.jad.2024.10.104_bb0350","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.psc.2019.10.013","article-title":"The neurobiology of mixed states","volume":"43","author":"Simonetti","year":"2020","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.jad.2024.10.104_bb0355","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1017\/S1092852916000869","article-title":"Mixed features in bipolar disorder","volume":"22","author":"Sol\u00e9","year":"2017","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2024.10.104_bb0360","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.4088\/JCP.v68n0713","article-title":"Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study","volume":"68","author":"Souery, D., Oswald, P., Massat, I., Bailer, U., Bollen, J., Demyttenaere, K., Kasper, S., Lecrubier, Y., Montgomery, S., Serretti, A., Zohar, J., Mendlewicz, J., Group for the Study of Resistant Depression","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2024.10.104_bb0365","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1017\/S1092852917000165","article-title":"Guidelines for the recognition and management of mixed depression","volume":"22","author":"Stahl","year":"2017","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2024.10.104_bb0370","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1001\/archpsyc.62.10.1089","article-title":"Mixed hypomania in 908 patients with bipolar disorder evaluated prospectively in the Stanley Foundation bipolar treatment network: a sex-specific phenomenon","volume":"62","author":"Suppes","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2024.10.104_bb0375","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1176\/appi.ajp.2015.15060770","article-title":"Lurasidone for the treatment of major depressive disorder with mixed features: a randomized, double-blind","volume":"173","author":"Suppes","year":"2016","journal-title":"Placebo-Controlled Study. Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.10.104_bb0380","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1503\/jpn.190098","article-title":"Magnetic seizure therapy is efficacious and well tolerated for treatment-resistant bipolar depression: an open-label clinical trial","volume":"45","author":"Tang","year":"2020","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.jad.2024.10.104_bb0385","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1017\/S1092852917000074","article-title":"Lurasidone for major depressive disorder with mixed features and anxiety: a post-hoc analysis of a randomized, placebo-controlled study","volume":"22","author":"Tsai","year":"2017","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2024.10.104_bb0390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203574","article-title":"Depression history and memory bias for specific daily emotions","volume":"13","author":"Urban","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jad.2024.10.104_bb0395","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jad.2017.09.006","article-title":"Mixed symptoms in major depressive and bipolar disorders: a systematic review","volume":"225","author":"V\u00e1zquez","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.10.104_bb0400","doi-asserted-by":"crossref","DOI":"10.3390\/ph16020287","article-title":"Efficacy of quetiapine monotherapy and combination therapy for patients with bipolar depression with mixed features: a randomized controlled pilot study","volume":"16","author":"Wang","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jad.2024.10.104_bb0405","doi-asserted-by":"crossref","first-page":"520","DOI":"10.4088\/JCP.13m08624","article-title":"Extended release quetiapine fumarate in patients with major depressive disorder: suicidality data from acute and maintenance studies","volume":"75","author":"Weisler","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2024.10.104_bb0410","article-title":"Type 2 diabetes mellitus is associated with manic morbidity in elderly patients with mood disorders","author":"Weiss","year":"2023","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.10.104_bb0415","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.10.104_bb0420","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jad.2023.07.102","article-title":"Identifying the DSM-5 mixed features specifier in depressed patients: a comparison of measures","volume":"339","author":"Zimmerman","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.10.104_bb0425","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.21ac13955","article-title":"Second-generation antipsychotics and suicide: a commentary","volume":"82","author":"Zuschlag","year":"2021","journal-title":"J. Clin. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032724018019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032724018019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T14:17:56Z","timestamp":1733494676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032724018019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":85,"alternative-id":["S0165032724018019"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2024.10.104","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypomanic symptoms in major depressive disorder: Prognostic impact and treatment issues","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2024.10.104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}